These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 39104818)

  • 1. Exploring the role of NLRP3 inflammasome in diabetic nephropathy and the advancements in herbal therapeutics.
    Jin J; Zhang M
    Front Endocrinol (Lausanne); 2024; 15():1397301. PubMed ID: 39104818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of traditional Chinese medicine in regulating NLRP3 inflammasomes to alleviate renal interstitial fibrosis in diabetic nephropathy: a review].
    Qiao L; Jin Y; Guo ZA
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1164-1171. PubMed ID: 38621963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular regulative mechanisms of NLRP3 inflammasome activation in diabetic nephropathy and interventional effects of Chinese herbal medicine].
    Wang WW; Han WB; Wan YG; Tu Y; Liu BH; Liu YL; Wu W; Yee HY; Fang QJ; Yao J
    Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):7-13. PubMed ID: 32237405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy.
    Wen L; Yang H; Ma L; Fu P
    Mol Cell Biochem; 2021 Mar; 476(3):1377-1386. PubMed ID: 33389490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
    Qiu YY; Tang LQ
    Pharmacol Res; 2016 Dec; 114():251-264. PubMed ID: 27826011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.
    Yang M; Wang X; Han Y; Li C; Wei L; Yang J; Chen W; Zhu X; Sun L
    Curr Med Chem; 2021; 28(42):8810-8824. PubMed ID: 34225600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
    Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
    Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificially Cultivated
    Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
    J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
    Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
    Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
    Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
    FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
    Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
    Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy.
    Zhao W; Zhou L; Novák P; Shi X; Lin CB; Zhu X; Yin K
    J Diabetes Res; 2022; 2022():2193768. PubMed ID: 35719709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats via NLRP3 inflammasomes.
    Zhang L; Jing M; Liu Q
    Life Sci; 2021 Aug; 278():119542. PubMed ID: 33915128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
    Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
    Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.
    Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD
    Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro.
    Li Y; Long W; Zhang H; Zhao M; Gao M; Guo W; Yu L
    Int Immunopharmacol; 2024 Apr; 131():111844. PubMed ID: 38503013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective effect of a novel combination of 6-gingerol and metformin in high-fat diet/streptozotocin-induced diabetic nephropathy in rats via targeting miRNA-146a, miRNA-223, TLR4/TRAF6/NLRP3 inflammasome pathway and HIF-1α.
    Aboismaiel MG; Amin MN; Eissa LA
    Biol Res; 2024 Jul; 57(1):47. PubMed ID: 39033184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.